JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A1882 Cediranib (AZD217)

Target: VEGFR

Summary: VEGFR inhibitor receptor,highly potent

≥22.52 mg/mL
A1736 PA-824
1 Citation

Summary: Anti-tuberculosis drug

insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
A1630 Epothilone B (EPO906, Patupilone)

Target: Microtubules/Tubulins

Summary: Microtubule stabilizing macrolide

≥25.4 mg/mL
A2487 Odanacatib (MK-0822)

Target: Cathepsins

Summary: Cathepsin K,potent and selective

insoluble in EtOH; insoluble in H2O; ≥17.7 mg/mL
A5932 Candesartan

Summary: Angiotensin II receptor 1 (AT1) antagonist

insoluble in H2O; ≥14.65 mg/mL
A5375 Tranilast

Summary: Angiogenesis inhibitor

≥32.7 mg/mL
A5316 Repaglinide

Summary: Kir6 (KATP) channel blocker
A5343 Ispinesib (SB-715992)

Target: Ksp

Summary: Kinesin spindle protein (KSP)inhibitor

≥25.85 mg/mL
A5919 AZD7762

Target: Chk

Summary: Checkpoint kinase inhibitor,ATP competitive

insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
A2033 PQ 401
1 Citation

Summary: IGF1R inhibitor,potent and cell-permeable

insoluble in H2O; ≥17.1 mg/mL